Cargando…

Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models

For the creation of a successful antibody–drug conjugate (ADC), both scientific and clinical evidence has indicated that highly toxic anticancer agents (ACA) should be conjugated to a monoclonal antibody (mAb) to administer a reasonable amount of ADC to patients without compromising the affinity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Yoshiyuki, Hyodo, Ichinosuke, Koga, Yoshikatsu, Tsumura, Ryo, Sato, Ryuta, Obonai, Toshihumi, Fuchigami, Hirobumi, Furuya, Fumiaki, Yasunaga, Masahiro, Harada, Mitsunori, Kato, Yasuki, Ohtsu, Atsushi, Matsumura, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452165/ https://www.ncbi.nlm.nih.gov/pubmed/25711681 http://dx.doi.org/10.1111/cas.12645

Ejemplares similares

Utility of epirubicin‐incorporating micelles tagged with anti‐tissue factor antibody clone with no anticoagulant effect
por: Sugaya, Akinori, et al.
Publicado: (2016)

Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts
por: Koga, Yoshikatsu, et al.
Publicado: (2015)

Tumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment
por: Obonai, Toshifumi, et al.
Publicado: (2016)

Preparation and characterization of anti-tissue factor single-chain variable fragment antibody for cancer diagnosis
por: Sato, Ryuta, et al.
Publicado: (2014)

Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
por: Fuchigami, Hirobumi, et al.
Publicado: (2018)

ET-05 PRECLINICAL STUDY OF AN ANTI-HUMAN TISSUE FACTOR ANTIBODY-DRUG CONJUGATE IN A MALIGNANT GLIOMA XENOGRAFT MODEL
por: Takashima, Hiroki, et al.
Publicado: (2019)

Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
por: Tsumura, Ryo, et al.
Publicado: (2019)

Function of Epirubicin-Conjugated Polymeric Micelles in Sonodynamic Therapy
por: Takemae, Kazuhisa, et al.
Publicado: (2019)

Characterization of antibody clones that bind exclusively to insoluble fibrin
por: Fuchigami, Hirobumi, et al.
Publicado: (2023)

Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model
por: Takashima, Hiroki, et al.
Publicado: (2017)

The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution
por: Yasunaga, Masahiro, et al.
Publicado: (2013)

Epirubicin-gold nanoparticles suppress hepatocellular carcinoma xenograft growth in nude mice
por: Meng, William C. S., et al.
Publicado: (2015)

Report of the use of patient‐derived xenograft models in the development of anticancer drugs in Japan
por: Tsumura, Ryo, et al.
Publicado: (2020)

Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines
por: Fukuoka, Shota, et al.
Publicado: (2016)

Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors
por: Koga, Yoshikatsu, et al.
Publicado: (2019)

Imaging mass spectrometry for the precise design of antibody-drug conjugates
por: Fujiwara, Yuki, et al.
Publicado: (2016)

Epirubicin
por: Cornish, J., et al.
Publicado: (1988)

High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer
por: Shiraishi, Takuya, et al.
Publicado: (2021)

NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo
por: Harada, Mitsunori, et al.
Publicado: (2012)

Development of Antibody–Drug Conjugates Using DDS and Molecular Imaging
por: Yasunaga, Masahiro, et al.
Publicado: (2017)

Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis
por: Moriwaki, Toshikazu, et al.
Publicado: (2021)

Stabilization of an (211)At-Labeled Antibody with Sodium Ascorbate
por: Manabe, Shino, et al.
Publicado: (2021)

Improved Recovery of Exfoliated Colonocytes from Feces Using Newly Developed Immunomagnetic Beads
por: Koga, Yoshikatsu, et al.
Publicado: (2008)

Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
por: Yamasaki, Miho, et al.
Publicado: (2019)

Radioimmunotherapy with an (211)At‐labeled anti–tissue factor antibody protected by sodium ascorbate
por: Takashima, Hiroki, et al.
Publicado: (2021)

Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer
por: Komatsu, Yoshito, et al.
Publicado: (2013)

Epirubicin-induced Kounis syndrome
por: Liang, Hui-zhu, et al.
Publicado: (2021)

Doxorubicin-Loaded PEG-PCL-PEG Micelle Using Xenograft Model of Nude Mice: Effect of Multiple Administration of Micelle on the Suppression of Human Breast Cancer
por: Cuong, Nguyen-Van, et al.
Publicado: (2010)

Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy
por: Moriwaki, Toshikazu, et al.
Publicado: (2016)

Development of polymeric micelles for targeting intractable cancers
por: Nishiyama, Nobuhiro, et al.
Publicado: (2016)

Alcohol is an oxidative stressor for gastric epithelial cells: detection of superoxide in living cells
por: Tamura, Masato, et al.
Publicado: (2013)

Acetaldehyde is an oxidative stressor for gastric epithelial cells
por: Tamura, Masato, et al.
Publicado: (2014)

Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific molecule
por: Yasunaga, Masahiro, et al.
Publicado: (2019)

PMP(Porphyrin–Micelle–PSMA) Nanoparticles for Photoacoustic and Ultrasound Signal Amplification in Mouse Prostate Cancer Xenografts
por: Kim, Daehyun, et al.
Publicado: (2021)

Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas.
por: Topham, C., et al.
Publicado: (1991)

Augmented antitumor activity of 5‐fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells
por: Imanishi, Mamiko, et al.
Publicado: (2019)

Vitamin C-driven epirubicin loading into liposomes
por: Lipka, Dominik, et al.
Publicado: (2013)

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin
por: Quiñones, Javier Pérez, et al.
Publicado: (2022)

Tumor Targeting of (211)At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis
por: Takashima, Hiroki, et al.
Publicado: (2022)

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer
por: Bonneterre, J, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_jdd0npjrvuani6g3t7kkbe92t4